Page last updated: 2024-12-05

zeatin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

Zeatin: An aminopurine factor in plant extracts that induces cell division. (Grant & Hackh's Chemical Dict, 5th ed) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID449093
CHEMBL ID525239
CHEBI ID16522
CHEBI ID15333
SCHEMBL ID49689
SCHEMBL ID3670336
SCHEMBL ID14876945
MeSH IDM0023121

Synonyms (87)

Synonym
smr000471895
MLS001074742
hsdb 7689
2-buten-1-ol, 2-methyl-4-(1h-purin-6-ylamino)-, (2e)-
unii-7i6ooj9gr6
7i6ooj9gr6 ,
AKOS015840012
AKOS015840013
CHEBI:16522 ,
(e)-2-methyl-4-(1h-purin-6-ylamino)-2-buten-1-ol
(e)-zeatin
(e)-2-methyl-4-(purin-6-ylamino)-2-buten-1-ol
2-buten-1-ol, 2-methyl-4-(1h-purin-6-ylamino)-, (e)-
2-buten-1-ol, 2-methyl-4-(purin-6-ylamino)-, (e)-
zeatine
brn 0616241
2-methyl-4-(9h-purin-6-ylamino)but-2-en-1-ol
CHEBI:15333
NCGC00017372-01
tnp00322
(2e)-2-methyl-4-(9h-purin-6-ylamino)but-2-en-1-ol
2-buten-1-ol, 2-methyl-4-(9h-purin-6-ylamino)-, (2e)-
inchi=1/c10h13n5o/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16h,3-4h2,1h3,(h2,11,12,13,14,15)/b7-2
n6-(4-hydroxyisopentenyl)adenine
zeatin
(e)-2-methyl-4-(1h-purin-6-ylamino)but-2-en-1-ol
C00371
1637-39-4
trans-zeatin ,
zeatin, bioreagent, plant cell culture tested, powder
trans-zeatin, bioreagent, plant cell culture tested, >=97%
(2z)-2-methyl-4-(9h-purin-6-ylamino)-2-buten-1-ol
NCGC00142544-01
2FLH
t-zeatin
(2e)-2-methyl-4-(1h-purin-6-ylamino)-2-buten-1-ol
trans-zeatin hydrochloride, plant cell culture tested, >=97%
94D98F16-103C-4126-89A0-1D32FEACC220
(e)-2-methyl-4-(7h-purin-6-ylamino)but-2-en-1-ol
131140-27-7
bdbm50267036
CHEMBL525239 ,
A810507
(e)-2-methyl-4-(7h-purin-6-ylamino)-2-buten-1-ol
A806205
AKOS015923020
HMS2269P18
NCGC00017372-02
6-(4-hydroxy-3-methyl-cis-2-butenylamino)purine
n6-(4-hydroxy-3-methyl-2-buten-1-yl)adenine
(e)-2-methyl-4-(9h-purin-6-ylamino)but-2-en-1-ol
zeatin [hsdb]
zeatin [mi]
zeatin [inci]
S4884
N89842
SCHEMBL49689
SCHEMBL3670336
(2e)-2-methyl-4-(7h-purin-6-ylamino)but-2-en-1-ol
J-200308
SCHEMBL14876945
UZKQTCBAMSWPJD-FARCUNLSSA-N
(2e)-2-methyl-4-(9h-purin-6-ylamino)-2-buten-1-ol
AC-22388
AC-30704
mth1 inhibitor, 131
bdbm227637
DTXSID9040631
mfcd00213654
(2e)-2-methyl-4-[(7h-purin-6-yl)amino]but-2-en-1-ol
(2z)-2-methyl-4-[(7h-purin-6-yl)amino]but-2-en-1-ol
CS-0016292
HY-19700
(e)-4-((9h-purin-6-yl)amino)-2-methylbut-2-en-1-ol ,
DB11337
AS-49891
Q2276562
Q22807318
AS-14879
BCP13132
2-buten-1-ol, 2-methyl-4-(9h-purin-6-ylamino)-
CCG-266716
AKOS037643348
A900233
(e/z)-zeatin
HY-19700A
CS-0147359

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The results indicated that significant dose-response relationship was observed between ABA contents and the concentrations of single fluoranthene and combined pollution of fluoranthene and benzo(a)pyrene, and ABA content responded more intensive to single fluoranthene than to combined treatment."( [Dose-response relationships between endogenous phytohormones of high plant and concentrations of fluoranthene and benzo(a)pyrene in soils].
Li, XY; Song, YF; Sun, TH; Zhou, QX, 2007
)
0.34
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
zeatin
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (17)

PathwayProteinsCompounds
Regulation of leaf development1722
cis-Zeatin-O-Glucoside Biosynthesis313
Cytokinins Degradation113
cis-Zeatin-N-Glucoside Biosynthesis314
lupinate biosynthesis05
trans-zeatin biosynthesis718
cytokinins 7-N-glucoside biosynthesis014
superpathway of indole-3-acetate conjugate biosynthesis828
cytokinins 9-N-glucoside biosynthesis015
indole-3-acetate inactivation IX017
cytokinins degradation114
cytokinin-O-glucosides biosynthesis614
Gravitropism under normal or artificial gravity environments5811
Regulation of lemma joints development and leaf angle by cytokinin111
cytokinins degradation519
cytokinins 7-N-glucoside biosynthesis219
cytokinins 9-N-glucoside biosynthesis217
trans-zeatin biosynthesis721
cytokinin-O-glucosides biosynthesis615
superpathway of indole-3-acetate conjugate biosynthesis533
Responses to stimuli: abiotic stimuli and stresses9526
Trans-zeatin biosynthesis022
Cytokinins conjugates biosynthesis08
Cytokinins 9-N-glucoside biosynthesis014
Cytokinins-O-glucoside biosynthesis06
Reproductive meristem phase change174

Protein Targets (9)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency1.12200.003245.467312,589.2998AID2517
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency2.81840.125919.1169125.8920AID2549
thyroid stimulating hormone receptorHomo sapiens (human)Potency19.95260.001318.074339.8107AID926; AID938
parathyroid hormone/parathyroid hormone-related peptide receptor precursorHomo sapiens (human)Potency11.22023.548119.542744.6684AID743266
lethal factor (plasmid)Bacillus anthracis str. A2012Potency12.58930.020010.786931.6228AID912
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)IC50 (µMol)18.00000.05201.20935.6000AID1802795
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, cytokinin-specific binding proteinVigna radiataKd106.0000106.0000106.0000106.0000AID977611
Histidine kinase 4Arabidopsis thaliana (thale cress)EC50 (µMol)1.10001.00003.03337.0000AID389121
Histidine kinase 3Arabidopsis thaliana (thale cress)EC50 (µMol)0.70000.70000.82500.9500AID389122
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (6)

Processvia Protein(s)Taxonomy
purine nucleoside catabolic process7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
DNA repair7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
response to oxidative stress7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
male gonad development7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
DNA protection7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
response to cadmium ion7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
5'-(N(7)-methylguanosine 5'-triphospho)-[mRNA] hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
protein binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
dATP diphosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
snoRNA binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
metal ion binding7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
ATP diphosphatase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
2-hydroxy-ATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
2-hydroxy-dATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
N6-methyl-(d)ATP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
O6-methyl-dGTP hydrolase activity7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
acrosomal vesicle7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
extracellular space7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
nucleus7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytoplasm7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
mitochondrion7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
mitochondrial matrix7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytosol7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
nuclear membrane7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
cytoplasm7,8-dihydro-8-oxoguanine triphosphataseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID389128Cytokinin-like effect in Amaranthus cotyledons assessed as dark induction of betacyanin synthesis at 100 umol/L relative to 6-benzylaminopurine2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID389123Inhibition of sArabidopsis thaliana CKX2 expressed in Saccharomyces cerevisiae 23344c ura-2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID389131Cytokinin-like effect in wheat assessed as retention of chlorophyll in excised leaves at 100 umol/L by senescence assay relative to 6-benzylaminopurine2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID389121Activation of Arabidopsis thaliana AHK4/CRE1 receptor expressed in Escherichia coli KMI001 by beta-galactosidase activity2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID416151Activation of Arabidopsis thaliana AHK3 expressed in Escherichia coli by beta galactosidase reporter gene assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives.
AID416152Activation of Arabidopsis thaliana CRE1/AHK4 expressed in Escherichia coli by beta galactosidase reporter gene assay2009Bioorganic & medicinal chemistry, Mar-01, Volume: 17, Issue:5
Synthesis, characterization and biological activity of ring-substituted 6-benzylamino-9-tetrahydropyran-2-yl and 9-tetrahydrofuran-2-ylpurine derivatives.
AID1191951Inhibition of BRD4 bromodomain-1 (unknown origin) at 100 uM by europium based LANCE TR-FRET assay2015Bioorganic & medicinal chemistry, Mar-01, Volume: 23, Issue:5
Discovery and structure-activity relationship studies of N6-benzoyladenine derivatives as novel BRD4 inhibitors.
AID389122Activation of Arabidopsis thaliana AHK3 receptor expressed in Escherichia coli KMI001 by beta-galactosidase activity2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID389125Cytokinin-like effect in tobacco assessed as stimulation of callus growth at 10 umol/L relative to 6-benzylaminopurine2008Bioorganic & medicinal chemistry, Oct-15, Volume: 16, Issue:20
Novel potent inhibitors of A. thaliana cytokinin oxidase/dehydrogenase.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2006The Plant cell, Oct, Volume: 18, Issue:10
Crystal structure of Vigna radiata cytokinin-specific binding protein in complex with zeatin.
AID1811Experimentally measured binding affinity data derived from PDB2006The Plant cell, Oct, Volume: 18, Issue:10
Crystal structure of Vigna radiata cytokinin-specific binding protein in complex with zeatin.
AID1802795In Vitro MTH1 Enzymatic Assay from Article 10.1111/cbdd.12909: \\Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.\\2017Chemical biology & drug design, 06, Volume: 89, Issue:6
Identification and structure-activity relationship of purine derivatives as novel MTH1 inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (290)

TimeframeStudies, This Drug (%)All Drugs %
pre-199037 (12.76)18.7374
1990's22 (7.59)18.2507
2000's100 (34.48)29.6817
2010's88 (30.34)24.3611
2020's43 (14.83)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews4 (1.31%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other302 (98.69%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]